238 related articles for article (PubMed ID: 22545122)
41. Relevance of ABC Transporters in Drug Development.
Nwabufo CK
Curr Drug Metab; 2022; 23(6):434-446. PubMed ID: 35726814
[TBL] [Abstract][Full Text] [Related]
42. Role of ABC transporters in the pathogenesis of Alzheimer's disease.
Abuznait AH; Kaddoumi A
ACS Chem Neurosci; 2012 Nov; 3(11):820-31. PubMed ID: 23181169
[TBL] [Abstract][Full Text] [Related]
43. Multi-Drug Resistance ABC Transporter Inhibition Enhances Murine Ventral Prostate Stem/Progenitor Cell Differentiation.
Samant MD; Jackson CM; Felix CL; Jones AJ; Goodrich DW; Foster BA; Huss WJ
Stem Cells Dev; 2015 May; 24(10):1236-51. PubMed ID: 25567291
[TBL] [Abstract][Full Text] [Related]
44. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies.
Poller B; Gutmann H; Krähenbühl S; Weksler B; Romero I; Couraud PO; Tuffin G; Drewe J; Huwyler J
J Neurochem; 2008 Dec; 107(5):1358-68. PubMed ID: 19013850
[TBL] [Abstract][Full Text] [Related]
45. Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2).
Ieiri I
Drug Metab Pharmacokinet; 2012; 27(1):85-105. PubMed ID: 22123128
[TBL] [Abstract][Full Text] [Related]
46. ABC transporters as phenotypic markers and functional regulators of stem cells.
Bunting KD
Stem Cells; 2002; 20(1):11-20. PubMed ID: 11796918
[TBL] [Abstract][Full Text] [Related]
47. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.
Schinkel AH; Jonker JW
Adv Drug Deliv Rev; 2003 Jan; 55(1):3-29. PubMed ID: 12535572
[TBL] [Abstract][Full Text] [Related]
48. Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs.
Matsson P; Pedersen JM; Norinder U; Bergström CA; Artursson P
Pharm Res; 2009 Aug; 26(8):1816-31. PubMed ID: 19421845
[TBL] [Abstract][Full Text] [Related]
49. Detergent-free purification of ABC (ATP-binding-cassette) transporters.
Gulati S; Jamshad M; Knowles TJ; Morrison KA; Downing R; Cant N; Collins R; Koenderink JB; Ford RC; Overduin M; Kerr ID; Dafforn TR; Rothnie AJ
Biochem J; 2014 Jul; 461(2):269-78. PubMed ID: 24758594
[TBL] [Abstract][Full Text] [Related]
50. Sildenafil is not a useful modulator of ABCB1 and ABCG2 mediated drug resistance in vivo.
Lin F; Hoogendijk L; Buil L; Beijnen JH; van Tellingen O
Eur J Cancer; 2013 May; 49(8):2059-64. PubMed ID: 23422148
[TBL] [Abstract][Full Text] [Related]
51. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
[TBL] [Abstract][Full Text] [Related]
52. Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells.
Pfister O; Oikonomopoulos A; Sereti KI; Sohn RL; Cullen D; Fine GC; Mouquet F; Westerman K; Liao R
Circ Res; 2008 Oct; 103(8):825-35. PubMed ID: 18787193
[TBL] [Abstract][Full Text] [Related]
53. Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cells.
Issa ME; Hall SR; Dupuis SN; Graham CL; Jakeman DL; Goralski KB
Anticancer Drugs; 2014 Mar; 25(3):255-69. PubMed ID: 24231527
[TBL] [Abstract][Full Text] [Related]
54. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
55. Interactions between Maraviroc and the ABCB1, ABCG2, and ABCC2 Transporters: An Important Role in Transplacental Pharmacokinetics.
Tupova L; Ceckova M; Ambrus C; Sorf A; Ptackova Z; Gaborik Z; Staud F
Drug Metab Dispos; 2019 Sep; 47(9):954-960. PubMed ID: 31266750
[TBL] [Abstract][Full Text] [Related]
56. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.
Narang VS; Fraga C; Kumar N; Shen J; Throm S; Stewart CF; Waters CM
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C440-50. PubMed ID: 18524938
[TBL] [Abstract][Full Text] [Related]
57. Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary.
Bernstein HG; Hölzl G; Dobrowolny H; Hildebrandt J; Trübner K; Krohn M; Bogerts B; Pahnke J
Mech Ageing Dev; 2014; 141-142():12-21. PubMed ID: 25218792
[TBL] [Abstract][Full Text] [Related]
58. The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms.
Natarajan K; Bhullar J; Shukla S; Burcu M; Chen ZS; Ambudkar SV; Baer MR
Biochem Pharmacol; 2013 Feb; 85(4):514-24. PubMed ID: 23261525
[TBL] [Abstract][Full Text] [Related]
59. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
Zhu MM; Tong JL; Xu Q; Nie F; Xu XT; Xiao SD; Ran ZH
PLoS One; 2012; 7(8):e41763. PubMed ID: 22870247
[TBL] [Abstract][Full Text] [Related]
60. Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro.
Cihalova D; Staud F; Ceckova M
Cancer Chemother Pharmacol; 2015 Jul; 76(1):105-16. PubMed ID: 25986678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
